Compare IDEXX Laboratories, Inc. (IDXX) vs SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs SP Funds S&P 500 Sharia Industry Exclusions ETF — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while SP Funds S&P 500 Sharia Industry Exclusions ETF trades at $60.77 (market cap $3.39B). The key difference: IDEXX Laboratories, Inc. is far larger — about 11.9× SP Funds S&P 500 Sharia Industry Exclusions ETF's market cap, and SP Funds S&P 500 Sharia Industry Exclusions ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and SP Funds S&P 500 Sharia Industry Exclusions ETF for 64 Days on average.
| IDXX | SPUS | |
|---|---|---|
Market Cap | $40.43B | $3.39B |
Volume | 692,164 | 349,184 |
Sector | Health | Broad Market / Factor |
52-Week High | $766.68 | $61.15 |
52-Week Low | $504.70 | $46.65 |
Typical Hold Time | 46 Days | 64 Days |
Enterprise Value | $41.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $4.27 exceeding the $3.94 estimate. Revenue grew to $4.3 billion in 2025, and net income margin expanded to 25.03%. Recent acquisitions like CoVetAI aim to enhance veterinary workflow intelligence.
The outlook remains positive given robust profitability and analyst consensus, but risks include foreign exchange headwinds and competitive pressures. With a consensus price target of $665, representing ~30% upside, the stock offers growth potential for investors comfortable with its premium valuation multiples.
SPUS (SP Funds S&P 500 Sharia Industry Exclusions ETF) trades at $60.77, down 0.49% with a bearish short-term technical signal despite bullish moving averages. The ETF shows consistent dividend distributions of $0.03 per share. Technical indicators show mixed signals with RSI suggesting overbought conditions while ADX indicates strong trend momentum.
The ETF faces headwinds from significant short interest growth (174.5% increase in September 2026) while maintaining its Sharia-compliant investment strategy. Key risks include market volatility and sector concentration, though the S&P 500 exposure provides diversification benefits for investors seeking compliant equity exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About SP Funds S&P 500 Sharia Industry Exclusions ETF
SPUS tracks a market-cap weighted index of S&P 500 stocks that adhere to Sharia law. It screens out companies involved in non-compliant business activities such as alcohol, tobacco, gambling, and conventional finance, as well as excluding sectors like Aerospace & Defense, and Data Processing. By focusing on low-leverage stocks, SPUS provides investors with a value-conscious, ethically-aligned exposure to a diversified portfolio of large-cap U.S. equities.
Read more on SPUS →
